BioNTech SE (BNTX) FCF Margin Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 7,441.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | -348.00 |
| Jun 30, 2025 | -522,071.00 |
| Mar 31, 2025 | -34,127.00 |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -9,070.00 |
| Jun 30, 2024 | 257,522.00 |
| Mar 31, 2024 | -276,354.00 |
| Dec 31, 2023 | 4,062.00 |
| Sep 30, 2023 | -4,377.00 |
| Jun 30, 2023 | 253,106.00 |
| Mar 31, 2023 | -5,020.00 |
| Dec 31, 2022 | 2,547.00 |
| Sep 30, 2022 | 11,422.00 |
| Jun 30, 2022 | 12,244.00 |
| Mar 31, 2022 | -1,451.00 |
| Dec 31, 2021 | -289.00 |
| Sep 30, 2021 | -25,914.00 |
| Jun 30, 2021 | -3,474.00 |
| Mar 31, 2021 | -20,502.00 |
| Sep 30, 2020 | 11,351.00 |
| Jun 30, 2020 | -17,414.00 |
| Mar 31, 2020 | 10,086.00 |